Not in the top 1,000 by GitHub stars

RConsortium/pharma-skills

A collection of agent skills for BioPharma use cases GSDBench Intake https://rconsortium.github.io/pharma-skills/gsdbench-intake/

History

Review weekly changes to SKILL.md before updating. Dates mark the weeks in which we observed each version; checks apply to the recorded commits.

View weekly changes

_automation/benchmark-runner/SKILL.md

Week of Nov 2, 2026 · +0 / −0 lines

Before Network or broad shell → After Network or broad shell

e5db96d54ef5 → e5db96d54ef5

Diff text is unavailable under the recorded licenses. Line counts and the GitHub link remain available.

Compare on GitHub

Week of Oct 26, 2026 · Line counts unavailable

Before Not checked yet → After Network or broad shell

First observation → e5db96d54ef5

No earlier version was observed for comparison.

Compare on GitHub

_automation/benchmark-summary/SKILL.md

Week of Nov 2, 2026 · +0 / −0 lines

Before Instructions only → After Instructions only

e5db96d54ef5 → e5db96d54ef5

Diff text is unavailable under the recorded licenses. Line counts and the GitHub link remain available.

Compare on GitHub

Week of Oct 26, 2026 · Line counts unavailable

Before Not checked yet → After Instructions only

First observation → e5db96d54ef5

No earlier version was observed for comparison.

Compare on GitHub

_automation/issue-to-eval/SKILL.md

Week of Nov 2, 2026 · +0 / −0 lines

Before Local scripts → After Local scripts

e5db96d54ef5 → e5db96d54ef5

Diff text is unavailable under the recorded licenses. Line counts and the GitHub link remain available.

Compare on GitHub

Week of Oct 26, 2026 · Line counts unavailable

Before Not checked yet → After Local scripts

First observation → e5db96d54ef5

No earlier version was observed for comparison.

Compare on GitHub

_automation/weekly-summary/SKILL.md

Week of Nov 2, 2026 · +0 / −0 lines

Before Local scripts → After Local scripts

e5db96d54ef5 → e5db96d54ef5

Diff text is unavailable under the recorded licenses. Line counts and the GitHub link remain available.

Compare on GitHub

Week of Oct 26, 2026 · Line counts unavailable

Before Not checked yet → After Local scripts

First observation → e5db96d54ef5

No earlier version was observed for comparison.

Compare on GitHub

admiral/SKILL.md

Week of Nov 2, 2026 · +0 / −0 lines

Before Instructions only → After Instructions only

e5db96d54ef5 → e5db96d54ef5

Diff text is unavailable under the recorded licenses. Line counts and the GitHub link remain available.

Compare on GitHub

Week of Oct 26, 2026 · Line counts unavailable

Before Not checked yet → After Instructions only

First observation → e5db96d54ef5

No earlier version was observed for comparison.

Compare on GitHub

admiral/admiral-adae/SKILL.md

Week of Nov 2, 2026 · +0 / −0 lines

Before Instructions only → After Instructions only

e5db96d54ef5 → e5db96d54ef5

Diff text is unavailable under the recorded licenses. Line counts and the GitHub link remain available.

Compare on GitHub

Week of Oct 26, 2026 · Line counts unavailable

Before Not checked yet → After Instructions only

First observation → e5db96d54ef5

No earlier version was observed for comparison.

Compare on GitHub

admiral/admiral-adpc/SKILL.md

Week of Nov 2, 2026 · +0 / −0 lines

Before Network or broad shell → After Network or broad shell

e5db96d54ef5 → e5db96d54ef5

Diff text is unavailable under the recorded licenses. Line counts and the GitHub link remain available.

Compare on GitHub

Week of Oct 26, 2026 · Line counts unavailable

Before Not checked yet → After Network or broad shell

First observation → e5db96d54ef5

No earlier version was observed for comparison.

Compare on GitHub

admiral/admiral-adrs/SKILL.md

Week of Nov 2, 2026 · +0 / −0 lines

Before Instructions only → After Instructions only

e5db96d54ef5 → e5db96d54ef5

Diff text is unavailable under the recorded licenses. Line counts and the GitHub link remain available.

Compare on GitHub

Week of Oct 26, 2026 · Line counts unavailable

Before Not checked yet → After Instructions only

First observation → e5db96d54ef5

No earlier version was observed for comparison.

Compare on GitHub

admiral/admiral-adsl/SKILL.md

Week of Nov 2, 2026 · +0 / −0 lines

Before Instructions only → After Instructions only

e5db96d54ef5 → e5db96d54ef5

Diff text is unavailable under the recorded licenses. Line counts and the GitHub link remain available.

Compare on GitHub

Week of Oct 26, 2026 · Line counts unavailable

Before Not checked yet → After Instructions only

First observation → e5db96d54ef5

No earlier version was observed for comparison.

Compare on GitHub

admiral/admiral-adtte/SKILL.md

Week of Nov 2, 2026 · +0 / −0 lines

Before Instructions only → After Instructions only

e5db96d54ef5 → e5db96d54ef5

Diff text is unavailable under the recorded licenses. Line counts and the GitHub link remain available.

Compare on GitHub

Week of Oct 26, 2026 · Line counts unavailable

Before Not checked yet → After Instructions only

First observation → e5db96d54ef5

No earlier version was observed for comparison.

Compare on GitHub

admiral/admiral-bds/SKILL.md

Week of Nov 2, 2026 · +0 / −0 lines

Before Instructions only → After Instructions only

e5db96d54ef5 → e5db96d54ef5

Diff text is unavailable under the recorded licenses. Line counts and the GitHub link remain available.

Compare on GitHub

Week of Oct 26, 2026 · Line counts unavailable

Before Not checked yet → After Instructions only

First observation → e5db96d54ef5

No earlier version was observed for comparison.

Compare on GitHub

clinical-trial-ipd-sim/SKILL.md

Week of Nov 2, 2026 · +0 / −0 lines

Before Network or broad shell → After Network or broad shell

e5db96d54ef5 → e5db96d54ef5

Diff text is unavailable under the recorded licenses. Line counts and the GitHub link remain available.

Compare on GitHub

Week of Oct 26, 2026 · Line counts unavailable

Before Not checked yet → After Network or broad shell

First observation → e5db96d54ef5

No earlier version was observed for comparison.

Compare on GitHub

clinical-trial-simulation/SKILL.md

Week of Nov 2, 2026 · +0 / −0 lines

Before Local scripts → After Local scripts

e5db96d54ef5 → e5db96d54ef5

Diff text is unavailable under the recorded licenses. Line counts and the GitHub link remain available.

Compare on GitHub

Week of Oct 26, 2026 · Line counts unavailable

Before Not checked yet → After Local scripts

First observation → e5db96d54ef5

No earlier version was observed for comparison.

Compare on GitHub

group-sequential-design/SKILL.md

Week of Nov 2, 2026 · +0 / −0 lines

Before Local scripts → After Local scripts

e5db96d54ef5 → e5db96d54ef5

Diff text is unavailable under the recorded licenses. Line counts and the GitHub link remain available.

Compare on GitHub

Week of Oct 26, 2026 · Line counts unavailable

Before Not checked yet → After Local scripts

First observation → e5db96d54ef5

No earlier version was observed for comparison.

Compare on GitHub

km-digitizer/SKILL.md

Week of Nov 2, 2026 · +0 / −0 lines

Before Network or broad shell → After Network or broad shell

e5db96d54ef5 → e5db96d54ef5

Diff text is unavailable under the recorded licenses. Line counts and the GitHub link remain available.

Compare on GitHub

Week of Oct 26, 2026 · Line counts unavailable

Before Not checked yet → After Network or broad shell

First observation → e5db96d54ef5

No earlier version was observed for comparison.

Compare on GitHub

rounding/SKILL.md

Week of Nov 2, 2026 · +0 / −0 lines

Before Local scripts → After Local scripts

e5db96d54ef5 → e5db96d54ef5

Diff text is unavailable under the recorded licenses. Line counts and the GitHub link remain available.

Compare on GitHub

Week of Oct 26, 2026 · Line counts unavailable

Before Not checked yet → After Local scripts

First observation → e5db96d54ef5

No earlier version was observed for comparison.

Compare on GitHub

sdtm-oak/SKILL.md

Week of Nov 2, 2026 · +0 / −0 lines

Before Network or broad shell → After Network or broad shell

e5db96d54ef5 → e5db96d54ef5

Diff text is unavailable under the recorded licenses. Line counts and the GitHub link remain available.

Compare on GitHub

Week of Oct 26, 2026 · Line counts unavailable

Before Not checked yet → After Network or broad shell

First observation → e5db96d54ef5

No earlier version was observed for comparison.

Compare on GitHub

statistical-reviewer/SKILL.md

Week of Nov 2, 2026 · +0 / −0 lines

Before Instructions only → After Instructions only

e5db96d54ef5 → e5db96d54ef5

Diff text is unavailable under the recorded licenses. Line counts and the GitHub link remain available.

Compare on GitHub

Week of Oct 26, 2026 · Line counts unavailable

Before Not checked yet → After Instructions only

First observation → e5db96d54ef5

No earlier version was observed for comparison.

Compare on GitHub

View on GitHubAdd to my skills

Verified commit e5db96d54ef5a79cbfd06e2339a3351e4583f8da

git clone --filter=blob:none --no-checkout https://github.com/RConsortium/pharma-skills.git .hotskills/rconsortium-pharma-skills && git -C .hotskills/rconsortium-pharma-skills checkout --detach e5db96d54ef5a79cbfd06e2339a3351e4583f8da # Copy each selected skill directory from .hotskills/rconsortium-pharma-skills into .claude/skills/<skill-name>/
139GitHub stars
10stars in 7 days
18skills in this repository
4commits in 30 days

Heat

6.9
  • Star growth, last 7 daysNot available
  • Star growth, last 24 hoursNot available
  • Rank movement, last 7 daysNot available
  • Commits, last 30 daysNot available
  • Accounts asking about it through MCP, last 7 daysNot available
  • Hot votes this weekNot available

Heat never changes the order by stars, and sponsorship never touches it. How heat works

Stars over time

Oct 25, 2026Nov 6, 2026139

30-day change not yet available: not enough history.

Individual skills in this repository

How it works

benchmark-runner

When your agent uses it

Auto-discover all skills with evals in RConsortium/pharma-skills, benchmark each with vs. without skill using matched isolated sessions, and post scored results to the linked GitHub issue. Use whenever someone says "run benchmarks", "compare skill performance", "eval the skills", or wants to measure whether a skill improves output quality.

What it loads into context

Frontmatter

77 tokens

Always available to the agent

SKILL.md

5,524 tokens

When the skill is activated

Reference documents

1,798 tokens

Loaded on request

Token counts are estimates. Scripts run separately; they are not counted as reference context.

The playbook

  1. Model Selection — Series Label and Sub-Agent Model
  2. Routine Setup (one-time)
  3. GitHub Access — Use Whichever Method Works
  4. Phase Detection — Run Before Any Other Step
  5. Phase 1 — Agent A Run (With Skill)
  6. Phase 2 — Agent B Run + Scoring
  7. Execution Flow
  8. Notes on Model Name
  9. Notes on Distributed Selection
  10. Notes on Rate Limits
  11. Success Criteria

Scripts executed separately

  • scripts/generate_dashboard.py
  • scripts/get_next_eval.py
  • scripts/post_issue_comment.py
  • scripts/record_run_result.py
  • scripts/setup_r_env.sh

Files

  • CLAUDE_CODE_ROUTINE.mddoc532 bytes
  • LICENSEasset1,036 bytes
  • README.mddoc5,037 bytes
  • SKILL.mdcore21,379 bytes
  • SKILL.mdcore21,379 bytes
  • SKILL.mdcore21,379 bytes
  • SKILL.mdcore21,379 bytes
  • SKILL.mdcore21,379 bytes
  • SKILL.mdcore21,379 bytes
  • SKILL.mdcore21,379 bytes
  • SKILL.mdcore21,379 bytes
  • SKILL.mdcore21,379 bytes
  • SKILL.mdcore21,379 bytes
  • SKILL.mdcore21,379 bytes
  • SKILL.mdcore21,379 bytes
  • SKILL.mdcore21,379 bytes
  • SKILL.mdcore21,379 bytes
  • SKILL.mdcore21,379 bytes
  • SKILL.mdcore21,379 bytes
  • SKILL.mdcore21,379 bytes
  • SKILL.mdcore21,379 bytes
  • SKILL.mdcore21,379 bytes
  • SKILL.mdcore21,379 bytes
  • SKILL.mdcore21,379 bytes
  • image/devcontainer.pngasset33,922 bytes
  • runs/.gitkeepasset0 bytes
  • runs/README.mddoc501 bytes
  • scripts/generate_dashboard.pyruns2,374 bytes
  • scripts/get_next_eval.pyruns26,054 bytes
  • scripts/post_issue_comment.pyruns4,108 bytes
  • scripts/record_run_result.pyruns2,082 bytes
  • scripts/setup_r_env.shruns8,989 bytes
  • vscode-codespaces-setup.mddoc1,482 bytes

No excerpt is shown for this license. Read the source on GitHub.

View the complete source on GitHub

Skills included

  • benchmark-runner
  • benchmark-summary
  • issue-to-eval
  • weekly-summary
  • admiral
  • admiral-adae
  • admiral-adpc
  • admiral-adrs
  • admiral-adsl
  • admiral-adtte
  • admiral-bds
  • clinical-trial-ipd-sim
  • clinical-trial-simulation
  • group-sequential-design
  • km-digitizer
  • rounding
  • sdtm-oak
  • statistical-reviewer

Repository facts

License
No license detected
Created
Mar 4, 2026
Last pushed
Oct 23, 2026
Forks
33
Open issues
74
Project activity
Active

Before you install

Network or broad shell

Automated signals, not a guarantee

Checked Nov 4, 2026

Not fully analyzed: some files were too long, unreadable or missing. This never lowers the level.

Show 82 notes
  • _automation/benchmark-runner/SKILL.md:1 Analysis incomplete: Referenced executable target unavailable; not analyzed
  • _automation/benchmark-runner/SKILL.md:1 Analysis incomplete: Referenced executable target unavailable; not analyzed
  • _automation/benchmark-runner/SKILL.md:1 Analysis incomplete: Referenced executable target unavailable; not analyzed
  • _automation/benchmark-runner/SKILL.md:1 Analysis incomplete: Referenced executable target unavailable; not analyzed
  • _automation/benchmark-runner/SKILL.md:1 Analysis incomplete: Referenced executable target unavailable; not analyzed
  • _automation/benchmark-runner/SKILL.md:1 Analysis incomplete: Referenced executable target unavailable; not analyzed
  • _automation/benchmark-runner/SKILL.md:1 Analysis incomplete: Referenced executable target unavailable; not analyzed
  • _automation/benchmark-runner/SKILL.md:1 Analysis incomplete: Referenced executable target unavailable; not analyzed
  • _automation/benchmark-runner/SKILL.md:1 Analysis incomplete: Referenced executable target unavailable; not analyzed
  • _automation/benchmark-runner/SKILL.md:1 Analysis incomplete: Referenced executable target unavailable; not analyzed
  • _automation/benchmark-runner/SKILL.md:1 Analysis incomplete: Referenced executable target unavailable; not analyzed
  • _automation/benchmark-runner/SKILL.md:1 Analysis incomplete: Referenced executable target unavailable; not analyzed
  • _automation/benchmark-runner/SKILL.md:1 Analysis incomplete: Referenced executable target unavailable; not analyzed
  • _automation/benchmark-runner/SKILL.md:1 Analysis incomplete: Referenced executable target unavailable; not analyzed
  • _automation/benchmark-runner/SKILL.md:1 Analysis incomplete: Referenced executable target unavailable; not analyzed
  • _automation/benchmark-runner/SKILL.md:1 Analysis incomplete: Referenced executable target unavailable; not analyzed
  • _automation/benchmark-runner/SKILL.md:1 Analysis incomplete: Referenced executable target unavailable; not analyzed
  • _automation/benchmark-runner/SKILL.md:1 Analysis incomplete: Referenced executable target unavailable; not analyzed
  • _automation/benchmark-runner/SKILL.md:1 Analysis incomplete: Referenced executable target unavailable; not analyzed
  • _automation/benchmark-runner/SKILL.md:1 Analysis incomplete: Referenced executable target unavailable; not analyzed
Show all 457 signals by file

_automation/benchmark-runner/CLAUDE_CODE_ROUTINE.md

  • Network accessline 9
    If that path is not accessible, fetch from GitHub: https://github.com/RConsortium/pharma-skills/blob/main/_automation/benchmark-runner/SKILL.md
  • Network accessline 10
    https://github.com/RConsortium/pharma-skills/blob/main/_automation/benchmark-runner/SKILL.md

_automation/benchmark-runner/SKILL.md

  • Network accessline 10
    Repository: `RConsortium/pharma-skills` (https://github.com/RConsortium/pharma-skills)
  • Network accessline 27
    Create a single routine at [claude.ai/code/routines](https://claude.ai/code/routines):
  • Network accessline 75
    <!-- BENCHMARK_PARTIAL: {"eval_id":"github-issue-27","model":"Claude Routine","skill_sha":"b5ede6a...","issue_number":27,"blinded_map":{"candidate_1":"output_B","candidate_2":"output_A"},"agent_a_asset_url":"https://github.com/RConsortium/p
  • Network accessline 194
    # Get-or-create release, then POST to its upload_url with the zip as data-binary.   # See https://docs.github.com/en/rest/releases for the exact endpoints.
  • Network accessline 195
    # See https://docs.github.com/en/rest/releases for the exact endpoints.
  • Network accessline 201
    https://github.com/RConsortium/pharma-skills/releases/download/benchmark-results/benchmark_agent_a_{eval_id}.zip
  • Network accessline 290
    # Option B — curl (release assets are public for public repos; token only needed for private):
  • Network accessline 291
    curl -L "{agent_a_asset_url}" -o /tmp/benchmark_{id}/benchmark_agent_a_{eval_id}.zip
  • Network accessline 429
    --- <!-- BENCHMARK_COMPLETE: {"eval_id":"{id}","model":"{model}","skill_sha":"{skill_sha}"} --> *Posted automatically by `benchmark-runner` · Repo: https://github.com/RConsortium/pharma-skills*
  • Network accessline 431
    *Posted automatically by `benchmark-runner` · Repo: https://github.com/RConsortium/pharma-skills*
  • Access to secretsline 440
    [Credential-related source omitted]

_automation/benchmark-runner/scripts/generate_dashboard.py

  • Executable scriptline 1
    Executable file
  • Dangerous shell operationline 5
    - Score trend per eval (grouped by skill)

_automation/benchmark-runner/scripts/get_next_eval.py

  • Executable scriptline 1
    Executable file
  • Access to secretsline 18
    [Credential-related source omitted]
  • Access to secretsline 39
    [Credential-related source omitted]
  • Network accessline 50
    while True:         url = (             f"https://api.github.com/repos/{repo}/issues/{issue_number}/comments"
  • Network accessline 51
    url = (             f"https://api.github.com/repos/{repo}/issues/{issue_number}/comments"             f"?per_page=100&page={page}"
  • Network accessline 52
    f"https://api.github.com/repos/{repo}/issues/{issue_number}/comments"
  • Network accessline 53
    f"?per_page=100&page={page}"         )         request = urllib.request.Request(
  • Network accessline 54
    )         request = urllib.request.Request(             url,
  • Network accessline 55
    request = urllib.request.Request(
  • Network accessline 62
    },         )         with urllib.request.urlopen(request, timeout=30) as response:
  • Network accessline 63
    )         with urllib.request.urlopen(request, timeout=30) as response:             page_comments = json.loads(response.read().decode("utf-8"))
  • Network accessline 64
    with urllib.request.urlopen(request, timeout=30) as response:
  • Access to secretsline 174
    [Credential-related source omitted]
  • Access to secretsline 478
    [Credential-related source omitted]
  • Access to secretsline 495
    [Credential-related source omitted]
  • Dangerous shell operationline 640
    rm = e.get("_runs_model")
  • Dangerous shell operationline 646
    f"{'???' if rm is None else rm:>8} "

_automation/benchmark-runner/scripts/post_issue_comment.py

  • Executable scriptline 1
    Executable file
  • Access to secretsline 10
    [Credential-related source omitted]
  • Access to secretsline 16
    [Credential-related source omitted]
  • Network accessline 22
    raise RuntimeError("GH_TOKEN or GITHUB_TOKEN is not set")     data = json.dumps(payload).encode("utf-8") if payload is not None else None     request = urllib.request.Request(
  • Network accessline 23
    data = json.dumps(payload).encode("utf-8") if payload is not None else None     request = urllib.request.Request(         url,
  • Network accessline 24
    request = urllib.request.Request(
  • Network accessline 34
    method=method,     )     with urllib.request.urlopen(request, timeout=30) as response:
  • Network accessline 35
    )     with urllib.request.urlopen(request, timeout=30) as response:         return json.loads(response.read().decode("utf-8"))
  • Network accessline 36
    with urllib.request.urlopen(request, timeout=30) as response:
  • Network accessline 43
    while True:         url = (             f"https://api.github.com/repos/{repo}/issues/{issue_number}/comments"
  • Network accessline 44
    url = (             f"https://api.github.com/repos/{repo}/issues/{issue_number}/comments"             f"?per_page=100&page={page}"
  • Network accessline 45
    f"https://api.github.com/repos/{repo}/issues/{issue_number}/comments"
  • Network accessline 59
    def post_issue_comment(repo: str, issue_number: str, body: str) -> str:     data = _api_request(         f"https://api.github.com/repos/{repo}/issues/{issue_number}/comments",
  • Network accessline 60
    data = _api_request(         f"https://api.github.com/repos/{repo}/issues/{issue_number}/comments",         method="POST",
  • Network accessline 61
    f"https://api.github.com/repos/{repo}/issues/{issue_number}/comments",
  • Network accessline 68
    def update_issue_comment(repo: str, comment_id: int, body: str) -> str:     data = _api_request(         f"https://api.github.com/repos/{repo}/issues/comments/{comment_id}",
  • Network accessline 69
    data = _api_request(         f"https://api.github.com/repos/{repo}/issues/comments/{comment_id}",         method="PATCH",
  • Network accessline 70
    f"https://api.github.com/repos/{repo}/issues/comments/{comment_id}",

_automation/benchmark-runner/scripts/record_run_result.py

  • Executable scriptline 1
    Executable file

_automation/benchmark-runner/scripts/setup_r_env.sh

  • Executable scriptline 1
    #!/usr/bin/env bash
  • Dangerous shell operationline 12
    sudo apt-get update -qq
  • Dangerous shell operationline 13
    sudo apt-get install -y r-base
  • Dangerous shell operationline 25
    sudo apt-get install -y --no-install-recommends \
  • Network accessline 46
    if ! grep -q "${domain}" /etc/hosts 2>/dev/null; then     local ip     ip=$(curl -s --max-time 10 -w "%{remote_ip}" -o /dev/null "https://${domain}" 2>/dev/null || true)
  • Network accessline 47
    local ip     ip=$(curl -s --max-time 10 -w "%{remote_ip}" -o /dev/null "https://${domain}" 2>/dev/null || true)     if [ -n "${ip}" ]; then
  • Network accessline 48
    ip=$(curl -s --max-time 10 -w "%{remote_ip}" -o /dev/null "https://${domain}" 2>/dev/null || true)
  • Dangerous shell operationline 50
    echo "${ip} ${domain}" | sudo tee -a /etc/hosts > /dev/null
  • Network accessline 108
    'pak',     type  = 'source',     repos = 'https://cloud.r-project.org',
  • Network accessline 109
    type  = 'source',     repos = 'https://cloud.r-project.org',     quiet = FALSE
  • Network accessline 110
    repos = 'https://cloud.r-project.org',
  • Network accessline 124
    message('[setup] CRAN source build failed — trying r-lib CDN binary...') cdn_url <- sprintf(   'https://r-lib.github.io/p/pak/stable/%s/%s/%s',
  • Network accessline 125
    cdn_url <- sprintf(   'https://r-lib.github.io/p/pak/stable/%s/%s/%s',   .Platform\$pkgType, R.Version()\$os, R.Version()\$arch
  • Network accessline 126
    'https://r-lib.github.io/p/pak/stable/%s/%s/%s',
  • Network accessline 157
    # Always set curl + SSL-bypass as the download fallback.
  • Network accessline 159
    # load; system curl resolves using the /etc/hosts pin we set above.
  • Network accessline 167
    ppm_url <- if (nzchar(os_codename)) {   sprintf("https://packagemanager.posit.co/cran/__linux__/%s/latest", os_codename)
  • Network accessline 168
    sprintf("https://packagemanager.posit.co/cran/__linux__/%s/latest", os_codename)
  • Network accessline 180
    } else {   message("[setup] PPM unavailable — using CRAN.")   "https://cran.r-project.org"
  • Network accessline 181
    message("[setup] PPM unavailable — using CRAN.")   "https://cran.r-project.org" }
  • Network accessline 182
    "https://cran.r-project.org"

_automation/benchmark-runner/vscode-codespaces-setup.md

  • Network accessline 1
    ## 1. Create a codespace from Github  open https://github.com/codespaces and create a codespace under main from pharma-skills
  • Network accessline 2
    open https://github.com/codespaces and create a codespace under main from pharma-skills
  • Instruction override signalline 38
    claude --dangerously-skip-permissions

_automation/issue-to-eval/scripts/import_issue_eval.py

  • Executable scriptline 1
    Executable file

_automation/issue-to-eval/scripts/sync_benchmarks.py

  • Executable scriptline 1
    Executable file

_automation/weekly-summary/scripts/get_weekly_data.py

  • Executable scriptline 1
    Executable file

admiral/README.md

  • Network accessline 3
    Agent skills for deriving ADaM datasets using the [{admiral}](https://pharmaverse.github.io/admiral/)
  • Network accessline 92
    - [admiral documentation](https://pharmaverse.github.io/admiral/)
  • Network accessline 93
    - [CDISC ADaMIG v1.3](https://www.cdisc.org/standards/foundational/adam)
  • Network accessline 94
    - [pharmaverse examples](https://pharmaverse.github.io/examples/)

admiral/admiral-adae/DESIGN.md

  • Network accessline 227
    Benchmarks are tracked as GitHub issues with the `benchmark` and `eval` labels at https://github.com/RConsortium/pharma-skills/issues.
  • Network accessline 228
    https://github.com/RConsortium/pharma-skills/issues.

admiral/admiral-adae/README.md

  • Network accessline 3
    An agent skill for deriving ADaM Adverse Events Analysis Datasets (ADAE) using the [{admiral}](https://pharmaverse.github.io/admiral/) R package and the
  • Network accessline 4
    the [{admiral}](https://pharmaverse.github.io/admiral/) R package and the
  • Network accessline 88
    Benchmarks are tracked as GitHub issues with the `benchmark` and `eval` labels at https://github.com/RConsortium/pharma-skills/issues.
  • Network accessline 89
    https://github.com/RConsortium/pharma-skills/issues.
  • Network accessline 139
    - [admiral documentation](https://pharmaverse.github.io/admiral/)
  • Network accessline 140
    - [admiral ADAE vignette](https://pharmaverse.github.io/admiral/articles/adae.html)
  • Network accessline 141
    - [CDISC ADaMIG v1.3](https://www.cdisc.org/standards/foundational/adam)
  • Network accessline 142
    - [pharmaverse examples — ADAE](https://pharmaverse.github.io/examples/)
  • Network accessline 143
    - [xportr documentation](https://atorus-research.github.io/xportr/)

admiral/admiral-adae/benchmarks/README.md

  • Network accessline 34
    Inputs are generated from [`{pharmaversesdtm}`](https://pharmaverse.github.io/pharmaversesdtm/)
  • Network accessline 35
    and [`{pharmaverseadam}`](https://pharmaverse.github.io/pharmaverseadam/) — publicly available,

admiral/admiral-adae/references/admiral-adae-functions.md

  • Network accessline 4
    It is structured around **decision guidance** — which function to use in a given situation and why — not as a comprehensive API reference. For full signatures and examples see the [admiral documentation](https://pharmaverse.github.io/admira
  • Network accessline 6
    and examples see the [admiral documentation](https://pharmaverse.github.io/admiral/).

admiral/admiral-adpc/DESIGN.md

  • Network accessline 175
    admiral PR [#3199](https://github.com/pharmaverse/admiral/pull/3199) adds a
  • Network accessline 187
    Benchmarks are tracked as GitHub issues with the `benchmark` label at https://github.com/RConsortium/pharma-skills/issues.
  • Network accessline 188
    https://github.com/RConsortium/pharma-skills/issues.
  • Network accessline 195
    Issue [#172](https://github.com/RConsortium/pharma-skills/issues/172) (NCA

admiral/admiral-adpc/README.md

  • Network accessline 3
    An agent skill for deriving ADaM Pharmacokinetic Concentrations Analysis Datasets (ADPC, also called ADNCA) using the [{admiral}](https://pharmaverse.github.io/admiral/) R package.
  • Network accessline 5
    [{admiral}](https://pharmaverse.github.io/admiral/) R package.
  • Network accessline 98
    Benchmarks are tracked as GitHub issues with the `benchmark` label at https://github.com/RConsortium/pharma-skills/issues.
  • Network accessline 99
    https://github.com/RConsortium/pharma-skills/issues.
  • Network accessline 103
    - [admiral PK NCA and population PK vignette](https://pharmaverse.github.io/admiral/articles/pk_adnca.html)
  • Network accessline 104
    - [CDISC ADaM Implementation Guide for NCA (ADNCA)](https://www.cdisc.org/standards/foundational/adam)
  • Network accessline 105
    - [PKNCA](https://humanpred.github.io/pknca/)

admiral/admiral-adpc/SKILL.md

  • Broad permissionsline 1
    Unsupported or unresolved allowed-tools declaration

admiral/admiral-adpc/benchmarks/README.md

  • Network accessline 3
    Benchmarks for the `admiral-adpc` skill are tracked as GitHub issues with the `benchmark` label at https://github.com/RConsortium/pharma-skills/issues, and
  • Network accessline 4
    `benchmark` label at https://github.com/RConsortium/pharma-skills/issues, and
  • Network accessline 7
    Inputs come from [`{pharmaversesdtm}`](https://pharmaverse.github.io/pharmaversesdtm/)
  • Network accessline 8
    (PC, EX, VS) and [`{pharmaverseadam}`](https://pharmaverse.github.io/pharmaverseadam/)

admiral/admiral-adrs/DESIGN.md

  • Network accessline 186
    Benchmarks are tracked as GitHub issues with the `benchmark` and `eval` labels at https://github.com/RConsortium/pharma-skills/issues.
  • Network accessline 187
    https://github.com/RConsortium/pharma-skills/issues.

admiral/admiral-adrs/README.md

  • Network accessline 3
    An agent skill for deriving ADaM Tumor Response Analysis Datasets (ADRS) using the [{admiral}](https://pharmaverse.github.io/admiral/) and
  • Network accessline 4
    the [{admiral}](https://pharmaverse.github.io/admiral/) and
  • Network accessline 5
    [{admiralonco}](https://pharmaverse.github.io/admiralonco/) R packages.
  • Network accessline 91
    Benchmarks are tracked as GitHub issues with the `benchmark` and `eval` labels at https://github.com/RConsortium/pharma-skills/issues.
  • Network accessline 92
    https://github.com/RConsortium/pharma-skills/issues.
  • Network accessline 109
    - [admiralonco documentation](https://pharmaverse.github.io/admiralonco/)
  • Network accessline 110
    - [admiralonco ADRS vignette](https://pharmaverse.github.io/admiralonco/articles/adrs.html)
  • Network accessline 111
    - [CDISC ADaMIG v1.3](https://www.cdisc.org/standards/foundational/adam)
  • Network accessline 112
    - [RECIST 1.1 guidelines](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107559/)
  • Network accessline 113
    - [pharmaverse examples — ADRS](https://pharmaverse.github.io/examples/)

admiral/admiral-adrs/benchmarks/README.md

  • Network accessline 34
    Issue [#167](https://github.com/RConsortium/pharma-skills/issues/167) was run
  • Network accessline 40
    Inputs are generated from [`{pharmaversesdtm}`](https://pharmaverse.github.io/pharmaversesdtm/) using
  • Network accessline 41
    [`{pharmaversesdtm}`](https://pharmaverse.github.io/pharmaversesdtm/) using

admiral/admiral-adsl/README.md

  • Network accessline 3
    An agent skill for deriving ADaM Subject-Level Analysis Datasets (ADSL) using the [{admiral}](https://pharmaverse.github.io/admiral/) R package and the
  • Network accessline 4
    the [{admiral}](https://pharmaverse.github.io/admiral/) R package and the
  • Network accessline 149
    - [admiral documentation](https://pharmaverse.github.io/admiral/)
  • Network accessline 150
    - [admiral ADSL vignette](https://pharmaverse.github.io/admiral/articles/adsl.html)
  • Network accessline 151
    - [CDISC ADaMIG v1.3](https://www.cdisc.org/standards/foundational/adam)
  • Network accessline 152
    - [pharmaverse examples — ADSL](https://pharmaverse.github.io/examples/)
  • Network accessline 153
    - [xportr documentation](https://atorus-research.github.io/xportr/)

admiral/admiral-adsl/benchmarks/README.md

  • Network accessline 35
    Inputs are generated from [`{pharmaversesdtm}`](https://pharmaverse.github.io/pharmaversesdtm/)
  • Network accessline 36
    and [`{pharmaverseadam}`](https://pharmaverse.github.io/pharmaverseadam/) — publicly available,

admiral/admiral-adsl/references/admiral-functions.md

  • Network accessline 4
    It is structured around **decision guidance** — which function to use in a given situation and why — not as a comprehensive API reference. For full signatures and examples see the [admiral documentation](https://pharmaverse.github.io/admira
  • Network accessline 4
    It is structured around **decision guidance** — which function to use in a given situation and why — not as a comprehensive API reference. For full signatures and examples see the [admiral documentation](https://pharmaverse.github.io/admira
  • Network accessline 6
    and examples see the [admiral documentation](https://pharmaverse.github.io/admiral/).
  • Network accessline 6
    and examples see the [admiral documentation](https://pharmaverse.github.io/admiral/).

admiral/admiral-adtte/DESIGN.md

  • Network accessline 139
    Benchmarks are tracked as GitHub issues with the `benchmark` and `eval` labels at https://github.com/RConsortium/pharma-skills/issues.
  • Network accessline 140
    https://github.com/RConsortium/pharma-skills/issues.
  • Network accessline 142
    Issue [#166](https://github.com/RConsortium/pharma-skills/issues/166) is the

admiral/admiral-adtte/README.md

  • Network accessline 3
    An agent skill for deriving ADaM Time-to-Event Analysis Datasets (ADTTE) using the [{admiral}](https://pharmaverse.github.io/admiral/) R package.
  • Network accessline 4
    the [{admiral}](https://pharmaverse.github.io/admiral/) R package.
  • Network accessline 88
    Benchmarks are tracked as GitHub issues with the `benchmark` and `eval` labels at https://github.com/RConsortium/pharma-skills/issues.
  • Network accessline 89
    https://github.com/RConsortium/pharma-skills/issues.
  • Network accessline 91
    The existing [#166](https://github.com/RConsortium/pharma-skills/issues/166)
  • Network accessline 97
    - [admiral ADTTE vignette](https://pharmaverse.github.io/admiral/articles/adtte.html)
  • Network accessline 98
    - [CDISC ADaMIG BDS-TTE v1.0](https://www.cdisc.org/standards/foundational/adam)
  • Network accessline 99
    - [pharmaverse examples — ADTTE](https://pharmaverse.github.io/examples/)

admiral/admiral-adtte/benchmarks/README.md

  • Network accessline 26
    Issue [#166](https://github.com/RConsortium/pharma-skills/issues/166) was run
  • Network accessline 32
    Inputs use [`{pharmaversesdtm}`](https://pharmaverse.github.io/pharmaversesdtm/)
  • Network accessline 33
    `ae` and [`{pharmaverseadam}`](https://pharmaverse.github.io/pharmaverseadam/)

admiral/admiral-bds/README.md

  • Network accessline 3
    An agent skill for deriving ADaM Basic Data Structure (BDS) findings datasets using the [{admiral}](https://pharmaverse.github.io/admiral/) R package and
  • Network accessline 4
    using the [{admiral}](https://pharmaverse.github.io/admiral/) R package and
  • Network accessline 128
    - [admiral ADVS vignette](https://pharmaverse.github.io/admiral/articles/advs.html)
  • Network accessline 129
    - [admiral ADLB vignette](https://pharmaverse.github.io/admiral/articles/adlb.html)
  • Network accessline 130
    - [CDISC ADaMIG v1.3 — BDS](https://www.cdisc.org/standards/foundational/adam)
  • Network accessline 131
    - [pharmaverse examples — BDS](https://pharmaverse.github.io/examples/)

admiral/admiral-bds/benchmarks/README.md

  • Network accessline 35
    Inputs are generated from [`{pharmaversesdtm}`](https://pharmaverse.github.io/pharmaversesdtm/)
  • Network accessline 36
    and [`{pharmaverseadam}`](https://pharmaverse.github.io/pharmaverseadam/) — publicly available,

clinical-trial-ipd-sim/SKILL.md

  • Network accessline 54
    ### Step 1 · Intake from ClinicalTrials.gov + protocol acquisition 1. Fetch `https://clinicaltrials.gov/api/v2/studies/{NCT}?format=json`; extract design (arms,
  • Network accessline 55
    1. Fetch `https://clinicaltrials.gov/api/v2/studies/{NCT}?format=json`; extract design (arms,

clinical-trial-ipd-sim/examples/allergy/cath/DAG.md

  • Network accessline 31
    - **[S1]** `paperclip: PMC2686169 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686169/` — Liu et al., *PLoS ONE* 2009. Vitamin-D-receptor activation directly induces cathelicidin and β-defensin (DEFB4); the CAMP promoter carries three VDRE
  • Network accessline 32
    - **[S2]** `paperclip: 2094036101 https://doi.org/10.1056/nejmoa021481` — Ong et al., *NEJM* 2002. AMP deficiency underlies *S. aureus* susceptibility in atopic dermatitis.
  • Network accessline 33
    - **[S3]** `paperclip: PMC10326740 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326740/` — Szabó et al., *Acta Derm Venereol* 2023. LL-37 (cathelicidin) is impaired in lesional and non-lesional AD.
  • Network accessline 34
    - **[S4]** `paperclip: PMC2782163 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782163/` — Kim et al., *J Korean Med Sci* 2005. LL-37 is negligible in normal skin but markedly increased in psoriasis.
  • Network accessline 35
    - **[S5]** `paperclip: 1528623386 https://doi.org/10.4049/jimmunol.179.2.984` — Albanesi et al., *J Immunol* 2007. IL-4 and IL-13 (TH2) negatively regulate β-defensin expression.
  • Network accessline 36
    - **[S6]** `paperclip: 2098825396 https://doi.org/10.1111/jdv.12176` — Hata et al., *JEADV* 2014 (this trial's own main-study RCT publication; PMID 23638978). Darker skin type and higher BMI are risk factors for vitamin D deficiency in AD.
  • Network accessline 37
    - **[S7]** `paperclip: 2128501903 https://doi.org/10.4172/2161-1165.1000148` — Jarrett, 2014 review. Oral vitamin D3 supplementation raises serum vitamin D.
  • Network accessline 38
    - **[S8]** `paperclip: 2151400905 https://doi.org/10.1046/j.0905-6157.2003.00106.x` — Laske et al., 2004. Serum IgE and atopic-dermatitis severity.

clinical-trial-ipd-sim/examples/allergy/cath/cath_dag_state.R

  • Access to secretsline 43
    [Credential-related source omitted]

clinical-trial-ipd-sim/examples/allergy/cath/cath_emit.R

  • Access to secretsline 7
    [Credential-related source omitted]
  • Access to secretsline 57
    [Credential-related source omitted]
  • Access to secretsline 61
    [Credential-related source omitted]
  • Access to secretsline 65
    [Credential-related source omitted]
  • Access to secretsline 71
    [Credential-related source omitted]
  • Access to secretsline 77
    [Credential-related source omitted]
  • Access to secretsline 82
    [Credential-related source omitted]
  • Access to secretsline 88
    [Credential-related source omitted]
  • Access to secretsline 92
    [Credential-related source omitted]
  • Access to secretsline 97
    [Credential-related source omitted]
  • Access to secretsline 101
    [Credential-related source omitted]

clinical-trial-ipd-sim/examples/allergy/cath/cath_longitudinal.R

  • Access to secretsline 67
    [Credential-related source omitted]
  • Access to secretsline 84
    [Credential-related source omitted]

clinical-trial-ipd-sim/examples/allergy/cath/params/params_final.json

  • Network accessline 43
    "S1": {         "paperclip_id": "PMC2686169",         "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686169/",
  • Network accessline 44
    "paperclip_id": "PMC2686169",         "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686169/",         "cite": "Liu et al., PLoS ONE 2009",
  • Network accessline 45
    "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686169/",
  • Network accessline 49
    "S2": {         "paperclip_id": "2094036101",         "url": "https://doi.org/10.1056/nejmoa021481",
  • Network accessline 50
    "paperclip_id": "2094036101",         "url": "https://doi.org/10.1056/nejmoa021481",         "cite": "Ong et al., NEJM 2002",
  • Network accessline 51
    "url": "https://doi.org/10.1056/nejmoa021481",
  • Network accessline 55
    "S3": {         "paperclip_id": "PMC10326740",         "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326740/",
  • Network accessline 56
    "paperclip_id": "PMC10326740",         "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326740/",         "cite": "Szabo et al., Acta Derm Venereol 2023",
  • Network accessline 57
    "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326740/",
  • Network accessline 61
    "S4": {         "paperclip_id": "PMC2782163",         "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782163/",
  • Network accessline 62
    "paperclip_id": "PMC2782163",         "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782163/",         "cite": "Kim et al., J Korean Med Sci 2005",
  • Network accessline 63
    "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782163/",
  • Network accessline 67
    "S5": {         "paperclip_id": "1528623386",         "url": "https://doi.org/10.4049/jimmunol.179.2.984",
  • Network accessline 68
    "paperclip_id": "1528623386",         "url": "https://doi.org/10.4049/jimmunol.179.2.984",         "cite": "Albanesi et al., J Immunol 2007",
  • Network accessline 69
    "url": "https://doi.org/10.4049/jimmunol.179.2.984",
  • Network accessline 73
    "S6": {         "paperclip_id": "2098825396",         "url": "https://doi.org/10.1111/jdv.12176",
  • Network accessline 74
    "paperclip_id": "2098825396",         "url": "https://doi.org/10.1111/jdv.12176",         "cite": "Hata et al., JEADV 2014 (this trial's main-study RCT publication, PMID 23638978)",
  • Network accessline 75
    "url": "https://doi.org/10.1111/jdv.12176",
  • Network accessline 79
    "S7": {         "paperclip_id": "2128501903",         "url": "https://doi.org/10.4172/2161-1165.1000148",
  • Network accessline 80
    "paperclip_id": "2128501903",         "url": "https://doi.org/10.4172/2161-1165.1000148",         "cite": "Jarrett et al., 2014 review",
  • Network accessline 81
    "url": "https://doi.org/10.4172/2161-1165.1000148",
  • Network accessline 85
    "S8": {         "paperclip_id": "2151400905",         "url": "https://doi.org/10.1046/j.0905-6157.2003.00106.x",
  • Network accessline 86
    "paperclip_id": "2151400905",         "url": "https://doi.org/10.1046/j.0905-6157.2003.00106.x",         "cite": "Laske et al., 2004",
  • Network accessline 87
    "url": "https://doi.org/10.1046/j.0905-6157.2003.00106.x",
  • Network accessline 91
    "S9": {         "paperclip_id": "4405923810",         "url": "https://doi.org/10.21873/invivo.13848",
  • Network accessline 92
    "paperclip_id": "4405923810",         "url": "https://doi.org/10.21873/invivo.13848",         "cite": "Kralova et al., In Vivo 2024 (abstract corpus) - 1000/2000/4000/8000 IU in young healthy adults",
  • Network accessline 93
    "url": "https://doi.org/10.21873/invivo.13848",

clinical-trial-ipd-sim/examples/allergy/cath/run_cath.R

  • Executable scriptline 1
    #!/usr/bin/env Rscript

clinical-trial-ipd-sim/examples/autoimmune/rave/DAG.md

  • Network accessline 92
    | Node | Parents | Equation | Source | Evidence | |---|---|---|---|---| | `WBC[t]` | `WBC[t−1]`, `baseline_wbc`, `cyc_active`, `rtx_infusion/is_rtx`, `aza_active`, `f_heme` | `0.5·WBC[t−1] + 0.5·base − drag + N(0, 0.7²)`; `drag = 1.7 + 0.7·
  • Network accessline 93
    |---|---|---|---|---| | `WBC[t]` | `WBC[t−1]`, `baseline_wbc`, `cyc_active`, `rtx_infusion/is_rtx`, `aza_active`, `f_heme` | `0.5·WBC[t−1] + 0.5·base − drag + N(0, 0.7²)`; `drag = 1.7 + 0.7·f_heme` (CYC), `0.6 + 0.4·f_heme` (RTX late), `0.6
  • Network accessline 94
    | `WBC[t]` | `WBC[t−1]`, `baseline_wbc`, `cyc_active`, `rtx_infusion/is_rtx`, `aza_active`, `f_heme` | `0.5·WBC[t−1] + 0.5·base − drag + N(0, 0.7²)`; `drag = 1.7 + 0.7·f_heme` (CYC), `0.6 + 0.4·f_heme` (RTX late), `0.6 + 0.3·f_heme` (AZA) |
  • Network accessline 107
    | `remission_day` | `remit_ever` | `clip(exp(Normal(log 45, 0.55²)), 8, 175)` | `model: params (remit_day_median)` | Median time-to-remission ~43–57 d (calibration target) | | `bvaswg[t]` | `bvaswg[t−1]`, `baseline_bvaswg`, `remission_day`,
  • Network accessline 108
    | `bvaswg[t]` | `bvaswg[t−1]`, `baseline_bvaswg`, `remission_day`, `day` | Linear decline to 0 by `remission_day` if remitting; else plateau at `0.45·baseline`; `=0` once in remission | `ctgov: outcomesModule` | BVAS/WG = 0 defines remissio
  • Network accessline 109
    | `flare[t]` | `is_rtx`, `anca_type`, `new_diagnosis`, `prednisone`, `f_relapse`, `in_remission`, `day` | `Bern(min(0.6, exp(log 0.045 − 0.20·rtx + 0.62·1{PR3} + 0.35·1{relapsing} − 0.020·pred + 1.0·f_relapse)))`, post-6mo only | `paperclip
  • Network accessline 118
    |---|---|---|---|---| | `Leukopenia / Neutropenia / Anaemia / Thrombocytopenia [t]` | `WBC/ANC/HGB/PLT[t]`, `cyc_active`, `aza_active` | Grade = CTCAE(lab); reported w.p. `{1:.20–.25, 2:.55–.85, 3:.95–.97, 4:1.0}`; serious only at Gr 4 | `c
  • Network accessline 119
    | `Leukopenia / Neutropenia / Anaemia / Thrombocytopenia [t]` | `WBC/ANC/HGB/PLT[t]`, `cyc_active`, `aza_active` | Grade = CTCAE(lab); reported w.p. `{1:.20–.25, 2:.55–.85, 3:.95–.97, 4:1.0}`; serious only at Gr 4 | `ctgov: resultsSection (
  • Network accessline 120
    | `Infection[t]` | `is_rtx`, `cyc/aza_active`, `prednisone`, `f_infect` | `Bern(min(0.6, exp(log 0.050 + 1.0·f_infect + 0.12·rtx + 0.004·pred)))`; serious fraction 0.30 | `paperclip: PMC5570101 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5

clinical-trial-ipd-sim/examples/autoimmune/rave/rave_emit.R

  • Access to secretsline 22
    [Credential-related source omitted]
  • Access to secretsline 24
    [Credential-related source omitted]
  • Access to secretsline 33
    [Credential-related source omitted]
  • Access to secretsline 34
    [Credential-related source omitted]
  • Access to secretsline 40
    [Credential-related source omitted]
  • Access to secretsline 48
    [Credential-related source omitted]
  • Access to secretsline 56
    [Credential-related source omitted]
  • Access to secretsline 64
    [Credential-related source omitted]
  • Access to secretsline 66
    [Credential-related source omitted]
  • Access to secretsline 75
    [Credential-related source omitted]
  • Access to secretsline 79
    [Credential-related source omitted]
  • Access to secretsline 83
    [Credential-related source omitted]

clinical-trial-ipd-sim/examples/autoimmune/rave/rave_metrics.R

  • Network accessline 37
    dm$is_leuko <- as.integer(dm$USUBJID %in% leuko_ids)   lk <- .arm_mean(dm, "ARMCD", "is_leuko");     m$leuko_RTX <- lk$RTX %||% 0; m$leuko_CYC <- lk$CYC %||% 0   re$nc <- as.integer(re$DISPOSITION != "COMPLETED")
  • Network accessline 38
    lk <- .arm_mean(dm, "ARMCD", "is_leuko");     m$leuko_RTX <- lk$RTX %||% 0; m$leuko_CYC <- lk$CYC %||% 0   re$nc <- as.integer(re$DISPOSITION != "COMPLETED")   nc <- .arm_mean(re, "ARMCD", "nc");           m$noncomplete_RTX <- nc$RTX %||% 0
  • Network accessline 39
    re$nc <- as.integer(re$DISPOSITION != "COMPLETED")
  • Network accessline 40
    nc <- .arm_mean(re, "ARMCD", "nc");           m$noncomplete_RTX <- nc$RTX %||% 0; m$noncomplete_CYC <- nc$CYC %||% 0

clinical-trial-ipd-sim/examples/autoimmune/rave/run_rave.R

  • Executable scriptline 1
    #!/usr/bin/env Rscript

clinical-trial-ipd-sim/find_protocol.md

  • Network accessline 8
    2. **find-protocol.** Otherwise run the vendored `find_protocol.py`, which turns an NCT ID into that    trial's full protocol PDF taken **strictly** from the public HuggingFace dataset    [`trialdesignbench/source`](https://huggingface.co/d
  • Network accessline 9
    trial's full protocol PDF taken **strictly** from the public HuggingFace dataset    [`trialdesignbench/source`](https://huggingface.co/datasets/trialdesignbench/source) — nothing from    ClinicalTrials.gov, NEJM, or anywhere else.
  • Network accessline 10
    [`trialdesignbench/source`](https://huggingface.co/datasets/trialdesignbench/source) — nothing from

clinical-trial-ipd-sim/paperclip.md

  • Dangerous shell operationline 15
    That script is just: `command -v paperclip || curl -fsSL https://paperclip.gxl.ai/install.sh | bash`.
  • Network accessline 15
    That script is just: `command -v paperclip || curl -fsSL https://paperclip.gxl.ai/install.sh | bash`.
  • Access to secretsline 17
    [Credential-related source omitted]
  • Network accessline 53
    Example row: `time_to_resistance (arm) | paperclip: pmc_8567001 https://… | "median PFS 25.5 vs 16.7 months (HR 0.62; 95% CI 0.49–0.79)"`.

clinical-trial-ipd-sim/scripts/setup_paperclip.sh

  • Executable scriptline 1
    #!/usr/bin/env bash
  • Network accessline 3
    command -v paperclip >/dev/null 2>&1 && { echo "paperclip already installed: $(command -v paperclip)"; exit 0; } echo "Installing paperclip CLI..."; curl -fsSL https://paperclip.gxl.ai/install.sh | bash
  • Dangerous shell operationline 4
    echo "Installing paperclip CLI..."; curl -fsSL https://paperclip.gxl.ai/install.sh | bash
  • Network accessline 4
    echo "Installing paperclip CLI..."; curl -fsSL https://paperclip.gxl.ai/install.sh | bash

clinical-trial-ipd-sim/templates/crf_schema_template.md

  • Network accessline 117
    Reference the CDISC SDTM domain model (the [SDTM model](https://www.cdisc.org/standards/foundational/sdtm) and the
  • Network accessline 118
    [SDTM model](https://www.cdisc.org/standards/foundational/sdtm) and the
  • Network accessline 119
    [SDTMIG](https://www.cdisc.org/standards/foundational/sdtmig)) to confirm the form set is

clinical-trial-ipd-sim/vendor/python/find_protocol/find_protocol.py

  • Executable scriptline 1
    Executable file
  • Network accessline 29
    BASE = "https://huggingface.co/datasets/trialdesignbench/source/resolve/main"
  • Network accessline 61
    for attempt in range(tries):         try:             r = requests.get(url, timeout=timeout, stream=bool(dest))
  • Network accessline 62
    try:             r = requests.get(url, timeout=timeout, stream=bool(dest))             if dest:
  • Network accessline 63
    r = requests.get(url, timeout=timeout, stream=bool(dest))

clinical-trial-ipd-sim/vendor/python/odm/build_spec.py

  • Executable scriptline 1
    Executable file

clinical-trial-ipd-sim/vendor/python/odm/check_columns.py

  • Executable scriptline 1
    Executable file

clinical-trial-ipd-sim/vendor/python/odm/check_odm.py

  • Executable scriptline 1
    Executable file
  • Network accessline 10
    HERE = os.path.dirname(os.path.abspath(__file__)) NS = "{http://www.cdisc.org/ns/odm/v2.0}"
  • Network accessline 11
    NS = "{http://www.cdisc.org/ns/odm/v2.0}"
  • Network accessline 12
    SCHEMA = os.path.join(HERE, "xsd_v2", "ODM.xsd")     # the rules from official ODM repo: https://github.com/cdisc-org/DataExchange-ODM/tree/main/schema

clinical-trial-ipd-sim/vendor/python/odm/emit_clinicaldata.py

  • Executable scriptline 1
    Executable file
  • Network accessline 16
    NS = "{http://www.cdisc.org/ns/odm/v2.0}"

clinical-trial-ipd-sim/vendor/python/odm/emit_odm.py

  • Executable scriptline 1
    Executable file
  • Network accessline 10
    NS = "http://www.cdisc.org/ns/odm/v2.0"
  • Network accessline 11
    XMLLANG = "{http://www.w3.org/XML/1998/namespace}lang"

clinical-trial-ipd-sim/vendor/python/odm/search_nci.py

  • Executable scriptline 1
    Executable file

clinical-trial-ipd-sim/vendor/python/odm/xsd_v2/ODM-admindata.xsd

  • Network accessline 1
    <?xml version="1.0" encoding="UTF-8"?> <xs:schema xmlns="http://www.cdisc.org/ns/odm/v2.0" xmlns:xs="http://www.w3.org/2001/XMLSchema"
  • Network accessline 2
    <xs:schema xmlns="http://www.cdisc.org/ns/odm/v2.0" xmlns:xs="http://www.w3.org/2001/XMLSchema"
  • Network accessline 3
    xmlns:odm="http://www.cdisc.org/ns/odm/v2.0" targetNamespace="http://www.cdisc.org/ns/odm/v2.0"
  • Network accessline 6
    <xs:import namespace="http://www.w3.org/XML/1998/namespace" schemaLocation="xml.xsd"/>

clinical-trial-ipd-sim/vendor/python/odm/xsd_v2/ODM-clinicaldata.xsd

  • Network accessline 1
    <?xml version="1.0" encoding="UTF-8"?> <xs:schema xmlns="http://www.cdisc.org/ns/odm/v2.0" xmlns:xs="http://www.w3.org/2001/XMLSchema"
  • Network accessline 2
    <xs:schema xmlns="http://www.cdisc.org/ns/odm/v2.0" xmlns:xs="http://www.w3.org/2001/XMLSchema"
  • Network accessline 3
    targetNamespace="http://www.cdisc.org/ns/odm/v2.0" elementFormDefault="qualified"
  • Network accessline 6
    <xs:import namespace="http://www.w3.org/XML/1998/namespace" schemaLocation="xml.xsd"/>

clinical-trial-ipd-sim/vendor/python/odm/xsd_v2/ODM-enumerations.xsd

  • Network accessline 1
    <?xml version="1.0" encoding="UTF-8"?> <xs:schema xmlns="http://www.cdisc.org/ns/odm/v2.0" xmlns:xs="http://www.w3.org/2001/XMLSchema"
  • Network accessline 2
    <xs:schema xmlns="http://www.cdisc.org/ns/odm/v2.0" xmlns:xs="http://www.w3.org/2001/XMLSchema"
  • Network accessline 3
    xmlns:nci="http://ncicb.nci.nih.gov/xml/odm/EVS/CDISC"
  • Network accessline 4
    xmlns:odm="http://www.cdisc.org/ns/odm/v2.0" targetNamespace="http://www.cdisc.org/ns/odm/v2.0"

clinical-trial-ipd-sim/vendor/python/odm/xsd_v2/ODM-foundation.xsd

  • Network accessline 1
    <xs:schema xmlns="http://www.cdisc.org/ns/odm/v2.0" xmlns:xs="http://www.w3.org/2001/XMLSchema"
  • Network accessline 2
    xmlns:odm="http://www.cdisc.org/ns/odm/v2.0"
  • Network accessline 3
    xmlns:xhtml="http://www.w3.org/1999/xhtml" targetNamespace="http://www.cdisc.org/ns/odm/v2.0"
  • Network accessline 6
    <xs:import namespace="http://www.w3.org/XML/1998/namespace" schemaLocation="xml.xsd"/>
  • Network accessline 7
    <xs:import namespace="http://www.w3.org/1999/xhtml" schemaLocation="ODM-xhtml.xsd"/>

clinical-trial-ipd-sim/vendor/python/odm/xsd_v2/ODM-protocol.xsd

  • Network accessline 1
    <?xml version="1.0" encoding="UTF-8"?> <xs:schema xmlns="http://www.cdisc.org/ns/odm/v2.0" xmlns:xs="http://www.w3.org/2001/XMLSchema"
  • Network accessline 2
    <xs:schema xmlns="http://www.cdisc.org/ns/odm/v2.0" xmlns:xs="http://www.w3.org/2001/XMLSchema"
  • Network accessline 3
    xmlns:odm="http://www.cdisc.org/ns/odm/v2.0" targetNamespace="http://www.cdisc.org/ns/odm/v2.0"
  • Network accessline 6
    <xs:import namespace="http://www.w3.org/XML/1998/namespace" schemaLocation="xml.xsd"/>

clinical-trial-ipd-sim/vendor/python/odm/xsd_v2/ODM-referencedata.xsd

  • Network accessline 1
    <?xml version="1.0" encoding="UTF-8"?> <xs:schema xmlns="http://www.cdisc.org/ns/odm/v2.0" xmlns:xs="http://www.w3.org/2001/XMLSchema"
  • Network accessline 2
    <xs:schema xmlns="http://www.cdisc.org/ns/odm/v2.0" xmlns:xs="http://www.w3.org/2001/XMLSchema"
  • Network accessline 3
    targetNamespace="http://www.cdisc.org/ns/odm/v2.0" elementFormDefault="qualified"
  • Network accessline 6
    <xs:import namespace="http://www.w3.org/XML/1998/namespace" schemaLocation="xml.xsd"/>

clinical-trial-ipd-sim/vendor/python/odm/xsd_v2/ODM-study.xsd

  • Network accessline 1
    <?xml version="1.0" encoding="UTF-8"?> <xs:schema xmlns="http://www.cdisc.org/ns/odm/v2.0" xmlns:xs="http://www.w3.org/2001/XMLSchema"
  • Network accessline 2
    <xs:schema xmlns="http://www.cdisc.org/ns/odm/v2.0" xmlns:xs="http://www.w3.org/2001/XMLSchema"
  • Network accessline 3
    xmlns:odm="http://www.cdisc.org/ns/odm/v2.0" targetNamespace="http://www.cdisc.org/ns/odm/v2.0"
  • Network accessline 4
    xmlns:xhtml="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink"
  • Network accessline 7
    <xs:import namespace="http://www.w3.org/XML/1998/namespace" schemaLocation="xml.xsd"/>
  • Network accessline 8
    <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="xlink.xsd"/>
  • Network accessline 9
    <xs:import namespace="http://www.w3.org/1999/xhtml" schemaLocation="ODM-xhtml.xsd"/>
  • Network accessline 19
    <!--              Added type to support expansion of TranslatedText.             Type is a Media Type as described in https://www.iana.org/assignments/media-types/media-types.xhtml
  • Network accessline 20
    Added type to support expansion of TranslatedText.             Type is a Media Type as described in https://www.iana.org/assignments/media-types/media-types.xhtml             A TranslatedText element with Type="text/plain" must be present.
  • Network accessline 21
    Type is a Media Type as described in https://www.iana.org/assignments/media-types/media-types.xhtml

clinical-trial-ipd-sim/vendor/python/odm/xsd_v2/ODM-types.xsd

  • Network accessline 1
    <?xml version="1.0" encoding="UTF-8"?> <xs:schema xmlns="http://www.cdisc.org/ns/odm/v2.0" xmlns:xs="http://www.w3.org/2001/XMLSchema"
  • Network accessline 2
    <xs:schema xmlns="http://www.cdisc.org/ns/odm/v2.0" xmlns:xs="http://www.w3.org/2001/XMLSchema"
  • Network accessline 3
    targetNamespace="http://www.cdisc.org/ns/odm/v2.0" elementFormDefault="qualified"
  • Network accessline 56
    as the IBM Mainframe format currently used in the submission V5 Transport standard as described in            SAS Technical Support document "TS-140 The Record Layout of a Data set in SAS Transport (XPORT) Format"            http://ftp.sas.
  • Network accessline 57
    SAS Technical Support document "TS-140 The Record Layout of a Data set in SAS Transport (XPORT) Format"            http://ftp.sas.com/techsup/download/technote/ts140.html         with the appropriate direct translation of the converted valu
  • Network accessline 58
    http://ftp.sas.com/techsup/download/technote/ts140.html

clinical-trial-ipd-sim/vendor/python/odm/xsd_v2/ODM-xhtml.xsd

  • Network accessline 1
    <U+FEFF><?xml version="1.0" encoding="UTF-8"?> <xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns="http://www.w3.org/1999/xhtml" targetNamespace="http://www.w3.org/1999/xhtml" elementFormDefault="qualified" version="1.0" xml:lang="en">
  • Network accessline 2
    <xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns="http://www.w3.org/1999/xhtml" targetNamespace="http://www.w3.org/1999/xhtml" elementFormDefault="qualified" version="1.0" xml:lang="en">
  • Network accessline 24
    - forms, objects, and inserted and deleted text   -->   <!-- Note: When using this schema with some tools, it may also be necessary to declare xmlns:xml="http://www.w3.org/XML/1998/namespace", however this causes performance issues with oth
  • Network accessline 25
    -->   <!-- Note: When using this schema with some tools, it may also be necessary to declare xmlns:xml="http://www.w3.org/XML/1998/namespace", however this causes performance issues with other tools and thus is not in the base schemas. --> 
  • Network accessline 26
    <!-- Note: When using this schema with some tools, it may also be necessary to declare xmlns:xml="http://www.w3.org/XML/1998/namespace", however this causes performance issues with other tools and thus is not in the base schemas. -->
  • Network accessline 34
    Namespace = http://www.w3.org/1999/xhtml
  • Network accessline 36
    For further information, see: http://www.w3.org/TR/xhtml1
  • Network accessline 43
    PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN"     SYSTEM "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"
  • Network accessline 44
    SYSTEM "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"
  • Network accessline 47
    </xs:documentation>   </xs:annotation>   <xs:import namespace="http://www.w3.org/XML/1998/namespace" schemaLocation="xml.xsd"/>
  • Network accessline 48
    </xs:annotation>   <xs:import namespace="http://www.w3.org/XML/1998/namespace" schemaLocation="xml.xsd"/>   <xs:annotation>
  • Network accessline 49
    <xs:import namespace="http://www.w3.org/XML/1998/namespace" schemaLocation="xml.xsd"/>
  • Network accessline 56
    PUBLIC "-//W3C//ENTITIES Latin 1 for XHTML//EN"     SYSTEM "http://www.w3.org/TR/xhtml1/DTD/xhtml-lat1.ent"
  • Network accessline 57
    SYSTEM "http://www.w3.org/TR/xhtml1/DTD/xhtml-lat1.ent"
  • Network accessline 59
    PUBLIC "-//W3C//ENTITIES Special for XHTML//EN"     SYSTEM "http://www.w3.org/TR/xhtml1/DTD/xhtml-special.ent"
  • Network accessline 60
    SYSTEM "http://www.w3.org/TR/xhtml1/DTD/xhtml-special.ent"
  • Network accessline 62
    PUBLIC "-//W3C//ENTITIES Symbols for XHTML//EN"     SYSTEM "http://www.w3.org/TR/xhtml1/DTD/xhtml-symbol.ent"
  • Network accessline 63
    SYSTEM "http://www.w3.org/TR/xhtml1/DTD/xhtml-symbol.ent"

clinical-trial-ipd-sim/vendor/python/odm/xsd_v2/ODM.xsd

  • Network accessline 1
    <?xml version="1.0" encoding="UTF-8"?> <xs:schema xmlns="http://www.cdisc.org/ns/odm/v2.0" xmlns:xs="http://www.w3.org/2001/XMLSchema"
  • Network accessline 2
    <xs:schema xmlns="http://www.cdisc.org/ns/odm/v2.0" xmlns:xs="http://www.w3.org/2001/XMLSchema"
  • Network accessline 3
    targetNamespace="http://www.cdisc.org/ns/odm/v2.0"
  • Network accessline 6
    <xs:import namespace="http://www.w3.org/XML/1998/namespace" schemaLocation="xml.xsd"/>

clinical-trial-ipd-sim/vendor/python/odm/xsd_v2/example_official_v2.xml

  • Network accessline 1
    <?xml version="1.0" encoding="UTF-8"?> <!-- Example Demographics form with "check all that apply" and "other, specify" for "Race".  Implemented as: Use Case D - CodeList repeat with "other" field - see https://wiki.cdisc.org/display/XMLT/De
  • Network accessline 2
    <!-- Example Demographics form with "check all that apply" and "other, specify" for "Race".  Implemented as: Use Case D - CodeList repeat with "other" field - see https://wiki.cdisc.org/display/XMLT/Details+of+Repeating+IG+Use+Cases+A-E -->
  • Network accessline 3
    Implemented as: Use Case D - CodeList repeat with "other" field - see https://wiki.cdisc.org/display/XMLT/Details+of+Repeating+IG+Use+Cases+A-E -->
  • Network accessline 4
    <ODM xmlns="http://www.cdisc.org/ns/odm/v2.0"
  • Network accessline 5
    xmlns:xs="http://www.w3.org/2001/XMLSchema"
  • Network accessline 6
    xmlns:xlink="http://www.w3.org/1999/xlink"
  • Network accessline 35
    </ItemGroupDef>          <!-- ItemGroup that repeats over all allowed values for "Race" (IT.RACE_CODE) from a codelist, with "Other, specifiy".          This corresponds to "Repeating Item Groups Use Case D" - see https://wiki.cdisc.org/dis
  • Network accessline 36
    <!-- ItemGroup that repeats over all allowed values for "Race" (IT.RACE_CODE) from a codelist, with "Other, specifiy".          This corresponds to "Repeating Item Groups Use Case D" - see https://wiki.cdisc.org/display/XMLT/Details+of+Repe
  • Network accessline 37
    This corresponds to "Repeating Item Groups Use Case D" - see https://wiki.cdisc.org/display/XMLT/Details+of+Repeating+IG+Use+Cases+A-E -->

clinical-trial-ipd-sim/vendor/python/odm/xsd_v2/xlink.xsd

  • Network accessline 1
    <?xml version="1.0" encoding="UTF-8" ?>  <xsd:schema targetNamespace="http://www.w3.org/1999/xlink"
  • Network accessline 2
    <xsd:schema targetNamespace="http://www.w3.org/1999/xlink"
  • Network accessline 3
    xmlns:xsd="http://www.w3.org/2001/XMLSchema"
  • Network accessline 4
    xmlns:xlink="http://www.w3.org/1999/xlink"

clinical-trial-ipd-sim/vendor/python/odm/xsd_v2/xml.xsd

  • Network accessline 1
    <?xml version='1.0'?> <xs:schema targetNamespace="http://www.w3.org/XML/1998/namespace"
  • Network accessline 2
    <xs:schema targetNamespace="http://www.w3.org/XML/1998/namespace"
  • Network accessline 3
    xmlns:xs="http://www.w3.org/2001/XMLSchema"
  • Network accessline 6
    <xs:annotation>   <xs:documentation>    See http://www.w3.org/XML/1998/namespace.html and
  • Network accessline 7
    <xs:documentation>    See http://www.w3.org/XML/1998/namespace.html and    http://www.w3.org/TR/REC-xml for information about this namespace.
  • Network accessline 8
    See http://www.w3.org/XML/1998/namespace.html and
  • Network accessline 9
    http://www.w3.org/TR/REC-xml for information about this namespace.
  • Network accessline 57
    &lt;schema . . .>          . . .          &lt;import namespace="http://www.w3.org/XML/1998/namespace"
  • Network accessline 58
    . . .          &lt;import namespace="http://www.w3.org/XML/1998/namespace"                     schemaLocation="http://www.w3.org/2001/03/xml.xsd"/>
  • Network accessline 59
    &lt;import namespace="http://www.w3.org/XML/1998/namespace"
  • Network accessline 60
    schemaLocation="http://www.w3.org/2001/03/xml.xsd"/>
  • Network accessline 74
    <xs:documentation>In keeping with the XML Schema WG's standard versioning    policy, this schema document will persist at    http://www.w3.org/2001/03/xml.xsd.
  • Network accessline 75
    policy, this schema document will persist at    http://www.w3.org/2001/03/xml.xsd.    At the date of issue it can also be found at
  • Network accessline 76
    http://www.w3.org/2001/03/xml.xsd.
  • Network accessline 77
    At the date of issue it can also be found at    http://www.w3.org/2001/xml.xsd.    The schema document at that URI may however change in the future,
  • Network accessline 78
    http://www.w3.org/2001/xml.xsd.
  • Network accessline 81
    itself.  In other words, if the XML Schema namespace changes, the version    of this document at    http://www.w3.org/2001/xml.xsd will change
  • Network accessline 82
    of this document at    http://www.w3.org/2001/xml.xsd will change    accordingly; the version at
  • Network accessline 83
    http://www.w3.org/2001/xml.xsd will change
  • Network accessline 84
    accordingly; the version at    http://www.w3.org/2001/03/xml.xsd will not change.   </xs:documentation>
  • Network accessline 85
    http://www.w3.org/2001/03/xml.xsd will not change.
  • Network accessline 106
    <xs:attribute name="base" type="xs:anyURI">   <xs:annotation>    <xs:documentation>See http://www.w3.org/TR/xmlbase/ for
  • Network accessline 107
    <xs:annotation>    <xs:documentation>See http://www.w3.org/TR/xmlbase/ for                      information about this attribute.
  • Network accessline 108
    <xs:documentation>See http://www.w3.org/TR/xmlbase/ for

clinical-trial-ipd-sim/vendor/python/render/render_trial_docs.py

  • Executable scriptline 1
    Executable file
  • Network accessline 253
    <meta name="viewport" content="width=device-width, initial-scale=1"> <title>__TITLE__</title> <script src="https://cdn.jsdelivr.net/npm/marked@12/marked.min.js"></script>
  • Network accessline 254
    <title>__TITLE__</title> <script src="https://cdn.jsdelivr.net/npm/marked@12/marked.min.js"></script> <script src="https://cdnjs.cloudflare.com/ajax/libs/cytoscape/3.33.2/cytoscape.min.js"></script>
  • Network accessline 255
    <script src="https://cdn.jsdelivr.net/npm/marked@12/marked.min.js"></script>
  • Network accessline 256
    <script src="https://cdnjs.cloudflare.com/ajax/libs/cytoscape/3.33.2/cytoscape.min.js"></script>
  • Network accessline 257
    <script src="https://cdn.jsdelivr.net/npm/dagre@0.8.5/dist/dagre.min.js"></script>
  • Network accessline 258
    <script src="https://cdn.jsdelivr.net/npm/cytoscape-dagre@2.5.0/cytoscape-dagre.min.js"></script>
  • Network accessline 259
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.16.11/dist/katex.min.css">
  • Network accessline 260
    <script src="https://cdn.jsdelivr.net/npm/katex@0.16.11/dist/katex.min.js"></script>
  • Network accessline 261
    <script src="https://cdn.jsdelivr.net/npm/katex@0.16.11/dist/contrib/auto-render.min.js"></script>
  • Possible obfuscationline 365
    const dec = (b64) => new TextDecoder('utf-8').decode(Uint8Array.from(atob(b64), c => c.charCodeAt(0)));

clinical-trial-simulation/README.md

  • Network accessline 3
    An agent skill for designing and simulating clinical trials using the [TrialSimulator](https://github.com/zhangh12/TrialSimulator) R package.
  • Network accessline 4
    [TrialSimulator](https://github.com/zhangh12/TrialSimulator) R package.
  • Network accessline 44
    - **R** ≥ 4.1 - **R packages** (CRAN unless noted):   - [TrialSimulator](https://github.com/zhangh12/TrialSimulator)
  • Network accessline 45
    - **R packages** (CRAN unless noted):   - [TrialSimulator](https://github.com/zhangh12/TrialSimulator)     (the simulation engine; install from GitHub for the latest)
  • Network accessline 46
    - [TrialSimulator](https://github.com/zhangh12/TrialSimulator)
  • Network accessline 53
    - `DoseFinding` (only if MCPMod-style dose ranging is used) - **Agent** capable of executing the   [Agent Skills Specification](https://github.com/anthropics/skills)
  • Network accessline 54
    - **Agent** capable of executing the   [Agent Skills Specification](https://github.com/anthropics/skills)   (Claude Code, or any compatible agent).
  • Network accessline 55
    [Agent Skills Specification](https://github.com/anthropics/skills)

clinical-trial-simulation/SKILL.md

  • Network accessline 67
    or when behavior contradicts these notes, consult `?<function>` in R or the package's pkgdown site at https://zhangh12.github.io/TrialSimulator/. Don't guess — the manual
  • Network accessline 68
    or the package's pkgdown site at https://zhangh12.github.io/TrialSimulator/. Don't guess — the manual is the source of truth.
  • Network accessline 69
    https://zhangh12.github.io/TrialSimulator/. Don't guess — the manual
  • Network accessline 214
    appear in tab-completion. The author flags this in the help docs (see the user-method list at the top of https://zhangh12.github.io/TrialSimulator/reference/Trials.html).
  • Network accessline 216
    https://zhangh12.github.io/TrialSimulator/reference/Trials.html).
  • Network accessline 602
    machinery but an endpoint generator that simulates the outcome   accounting for the changing treatment over time.   https://zhangh12.github.io/TrialSimulator/articles/crossoverWashout.html
  • Network accessline 603
    accounting for the changing treatment over time.   https://zhangh12.github.io/TrialSimulator/articles/crossoverWashout.html - **Dynamic treatment switching** — per-patient switching driven by each
  • Network accessline 604
    https://zhangh12.github.io/TrialSimulator/articles/crossoverWashout.html
  • Network accessline 607
    onward (e.g. switch at progression, rescue after non-response, dose   changes, and other outcome-driven changes).   https://zhangh12.github.io/TrialSimulator/articles/dynamicTreatmentSwitching.html
  • Network accessline 608
    changes, and other outcome-driven changes).   https://zhangh12.github.io/TrialSimulator/articles/dynamicTreatmentSwitching.html - **Crossover at a milestone** — crossover anchored to a trial-level time:
  • Network accessline 609
    https://zhangh12.github.io/TrialSimulator/articles/dynamicTreatmentSwitching.html
  • Network accessline 612
    (e.g. an interim efficacy signal opens crossover for control patients   still on study).   https://zhangh12.github.io/TrialSimulator/articles/crossoverAtMilestone.html
  • Network accessline 614
    https://zhangh12.github.io/TrialSimulator/articles/crossoverAtMilestone.html
  • Network accessline 644
    `Controllers`, use `?Trials` / `?Controllers` (method-level `?` does not work) or the pkgdown reference page. Vignettes live at https://zhangh12.github.io/TrialSimulator/articles/. Don't disable a
  • Network accessline 645
    not work) or the pkgdown reference page. Vignettes live at https://zhangh12.github.io/TrialSimulator/articles/. Don't disable a check to make an error go away.
  • Network accessline 646
    https://zhangh12.github.io/TrialSimulator/articles/. Don't disable a

clinical-trial-simulation/references/code_snippets.md

  • Network accessline 1091
    | Recipe | Vignette | |---|---| | §4, §19, §16 | https://zhangh12.github.io/TrialSimulator/articles/enrichmentDesign.html |
  • Network accessline 1092
    |---|---| | §4, §19, §16 | https://zhangh12.github.io/TrialSimulator/articles/enrichmentDesign.html | | §5 | https://zhangh12.github.io/TrialSimulator/articles/conditionalPower.html |
  • Network accessline 1093
    | §4, §19, §16 | https://zhangh12.github.io/TrialSimulator/articles/enrichmentDesign.html |
  • Network accessline 1094
    | §5 | https://zhangh12.github.io/TrialSimulator/articles/conditionalPower.html |
  • Network accessline 1095
    | §12, §14 | https://zhangh12.github.io/TrialSimulator/articles/adaptiveDesign.html |
  • Network accessline 1096
    | §15 | https://zhangh12.github.io/TrialSimulator/articles/responseAdaptive.html |
  • Network accessline 1097
    | §18 | https://zhangh12.github.io/TrialSimulator/articles/doseRanging.html |
  • Network accessline 1098
    | §20 | https://zhangh12.github.io/TrialSimulator/articles/crossoverAtMilestone.html |
  • Network accessline 1099
    | adaptation overview | https://zhangh12.github.io/TrialSimulator/articles/actionFunctions.html |

clinical-trial-simulation/references/helpers.md

  • Network accessline 7
    For full argument lists, consult `?<function>` in R or https://zhangh12.github.io/TrialSimulator/reference/.
  • Network accessline 8
    https://zhangh12.github.io/TrialSimulator/reference/.
  • Network accessline 345
    Canonical reference: the "Automatically Saved Results At Triggered Milestones" table in https://zhangh12.github.io/TrialSimulator/articles/actionFunctions.html.
  • Network accessline 347
    https://zhangh12.github.io/TrialSimulator/articles/actionFunctions.html.

clinical-trial-simulation/scripts/conversation_log.R

  • Executable scriptline 1
    #!/usr/bin/env Rscript

group-sequential-design/README.md

  • Network accessline 3
    A [Claude Code](https://claude.ai/code) skill that designs group sequential clinical trials for survival endpoints (OS, PFS, DFS). It collects trial parameters through a structured conversation, computes boundaries and sample sizes in R, ve
  • Network accessline 7
    https://drive.google.com/file/d/1O9-SCJEoXGJv6J3YXuZZ1eiVB4Jk6Gao/view
  • Network accessline 59
    ### R (>= 4.0) - [`gsDesign`](https://cran.r-project.org/package=gsDesign) — group sequential boundaries and sample size
  • Network accessline 60
    - [`gsDesign`](https://cran.r-project.org/package=gsDesign) — group sequential boundaries and sample size
  • Network accessline 61
    - [`gsDesign2`](https://cran.r-project.org/package=gsDesign2) — non-proportional hazards (AHR, analytical power)
  • Network accessline 62
    - [`lrstat`](https://cran.r-project.org/package=lrstat) — log-rank simulation for verification
  • Network accessline 63
    - [`graphicalMCP`](https://cran.r-project.org/package=graphicalMCP) — multiplicity diagrams
  • Network accessline 64
    - [`jsonlite`](https://cran.r-project.org/package=jsonlite) — JSON I/O
  • Network accessline 66
    ### Python (>= 3.8) - [`python-docx`](https://pypi.org/project/python-docx/) — Word report generation
  • Network accessline 67
    - [`python-docx`](https://pypi.org/project/python-docx/) — Word report generation

group-sequential-design/scripts/gsd_report_template.py

  • Executable scriptline 1
    #!/usr/bin/env python3

km-digitizer/SKILL.md

  • Network accessline 20
    - NEJM: look for image URLs containing `/full/` or `/figure/`    - Lancet/JCO: look for high-res figure links, often ending in `.jpg` or `.png`    - PubMed Central: figures are usually at predictable URLs like `https://www.ncbi.nlm.nih.gov/
  • Network accessline 21
    - Lancet/JCO: look for high-res figure links, often ending in `.jpg` or `.png`    - PubMed Central: figures are usually at predictable URLs like `https://www.ncbi.nlm.nih.gov/pmc/articles/PMC.../figure/...` 3. Download the KM plot image and
  • Network accessline 22
    - PubMed Central: figures are usually at predictable URLs like `https://www.ncbi.nlm.nih.gov/pmc/articles/PMC.../figure/...` 3. Download the KM plot image and save to `reference/KMPlot/<study_name>.png` 4. If the page is paywalled or the im

km-digitizer/scripts/digitize_km.py

  • Executable scriptline 1
    Executable file

km-digitizer/scripts/generate_report.py

  • Executable scriptline 1
    Executable file
  • Access to secretsline 37
    [Credential-related source omitted]
  • Access to secretsline 38
    [Credential-related source omitted]

km-digitizer/scripts/plot_km_hazard.R

  • Executable scriptline 1
    #!/usr/bin/env Rscript

km-digitizer/scripts/reconstruct_ipd.R

  • Executable scriptline 1
    #!/usr/bin/env Rscript

km-digitizer/scripts/setup_wizard.py

  • Executable scriptline 1
    #!/usr/bin/env python3

km-digitizer/scripts/survival_stats.R

  • Executable scriptline 1
    #!/usr/bin/env Rscript

km-digitizer/scripts/verify_reconstruction.R

  • Executable scriptline 1
    #!/usr/bin/env Rscript

rounding/README.md

  • Network accessline 30
    > "Audit rounding compliance of https://github.com/Merck/metalite.ae/tree/bdb23d472b16bc9dadbc774e64c5ca40321e9c6b against precision-spec.yml. Entry points are the `tlf_*()` functions; I'm the rule owner."

rounding/evals/README.md

  • Network accessline 3
    Test cases for the `rounding` skill, per `LIFECYCLE.md` phase 3 and the criteria in [`RConsortium/pharma-skills` issue #208](https://github.com/RConsortium/pharma-skills/issues/208).
  • Network accessline 5
    #208](https://github.com/RConsortium/pharma-skills/issues/208).

rounding/evals/fixtures/build-fixture.sh

  • Executable scriptline 1
    #!/usr/bin/env bash
  • Dangerous shell operationline 5
    rm -f myanalysis-fixture.zip

rounding/scripts/probe-tie-behavior.R

  • Executable scriptline 1
    #!/usr/bin/env Rscript

rounding/scripts/scan-rounding-calls.R

  • Executable scriptline 1
    #!/usr/bin/env Rscript

sdtm-oak/README.md

  • Network accessline 3
    An agent skill for deriving CDISC SDTM domains from raw EDC/eCRF data using the [{sdtm.oak}](https://pharmaverse.github.io/sdtm.oak/) pharmaverse R package.
  • Network accessline 4
    the [{sdtm.oak}](https://pharmaverse.github.io/sdtm.oak/) pharmaverse R package.
  • Network accessline 60
    - [sdtm.oak documentation](https://pharmaverse.github.io/sdtm.oak/)
  • Network accessline 61
    - [CDISC SDTM Implementation Guide](https://www.cdisc.org/standards/foundational/sdtm)
  • Network accessline 62
    - [pharmaverse](https://pharmaverse.org/)

sdtm-oak/SKILL.md

  • Broad permissionsline 1
    Unsupported or unresolved allowed-tools declaration

How the signals fit together

Facts from a static read of the files at the pinned commit. They describe what the code does, not why.

Some files could not be read; the facts below still hold.

Declared and executed: 11 facts
Signal confidence: 300 facts

and 250 more

Works with

Agent compatibility, from the files in this repository
AgentStatusEvidenceInstall to
Claude CodeNativePath .claude/settings.json.claude/skills/<skill-name>/
CodexCompatibleStandard SKILL.md _automation/benchmark-runner/SKILL.md.agents/skills/<skill-name>/
CursorCompatibleStandard SKILL.md _automation/benchmark-runner/SKILL.md.cursor/skills/<skill-name>/
Gemini CLICompatibleStandard SKILL.md _automation/benchmark-runner/SKILL.md.gemini/skills/<skill-name>/
GitHub CopilotCompatibleStandard SKILL.md _automation/benchmark-runner/SKILL.md.github/skills/<skill-name>/
OpenCodeCompatibleStandard SKILL.md _automation/benchmark-runner/SKILL.md.opencode/skills/<skill-name>/
  • Native The repository ships a manifest, folder or frontmatter field for this agent.
  • Compatible A standard SKILL.md that this agent can read.
  • Unknown No evidence either way.

Derived automatically from paths, manifests and frontmatter. Not tested on each agent.